Goflikicept
Goflikicept Uses, Dosage, Side Effects, Food Interaction and all others data.
Goflikicept is under investigation in clinical trial NCT04380519 (Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-cov-2) Infection (COVID-19)).
| Trade Name | Goflikicept |
| Generic | Goflikicept |
| Goflikicept Other Names | Goflikicept |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
How Goflikicept works
Goflikicept is a fusion protein that neutralizes interleukin-1B (IL-1B), affecting its signalling pathways. As IL-1B is involved in 'cytokine storm' efects, goflikicept's effects on the molecule inhibits widespread inflammation.
Innovators Monograph
You find simplified version here Goflikicept
